Koss-Olinger Consulting’s Sanofi SNY Stock Holding History

Koss-Olinger Consulting’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,767	Closed	-$230K	–	309
2025 Q3	$230K	Hold	4,767	–	–	0.02%	287
2025 Q2	$230K	Sell	4,767 -195	-4%	-$9.96K	0.02%	291
2025 Q1	$275K	Buy	+4,962	New	+$269K	0.02%	261
2024 Q4	–	Sell	-4,962	Closed	-$286K	–	270
2024 Q3	$286K	Hold	4,962	–	–	0.02%	232
2024 Q2	$241K	Buy	+4,962	New	+$239K	0.02%	231
2024 Q1	–	Sell	-5,192	Closed	-$258K	–	263
2023 Q4	$258K	Hold	5,192	–	–	0.03%	258
2023 Q3	$278K	Buy	5,192 +95	+2%	+$5.07K	0.04%	200
2023 Q2	$275K	Hold	5,097	–	–	0.03%	200
2023 Q1	$277K	Sell	5,097 -163	-3%	-$7.93K	0.03%	184
2022 Q4	$255K	Buy	+5,260	New	+$231K	0.04%	174
2021 Q4	–	Sell	-6,162	Closed	-$297K	–	252
2021 Q3	$297K	Sell	6,162 -174	-3%	-$8.85K	0.05%	172
2021 Q2	$334K	Buy	6,336 +506	+9%	+$26.4K	0.05%	177
2021 Q1	$288K	Buy	+5,830	New	+$280K	0.05%	174

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Koss-Olinger Consulting's SNY Position: Q4 2025 in Review

Koss-Olinger Consulting sold out of Sanofi (SNY) in Q4 2025, closing a stake of 4,767 shares — an estimated $230K sold.

Koss-Olinger Consulting first reported a position in SNY in Q1 2021 and held it in 13 quarters. The position peaked at $334K in Q2 2021. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Koss-Olinger Consulting reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Koss-Olinger Consulting sold 4,767 Sanofi shares in Q4 2025, an estimated $230K.
Koss-Olinger Consulting first reported a position in Sanofi in Q1 2021 and held it in 13 quarters.
Koss-Olinger Consulting's Sanofi position peaked at $334K in Q2 2021.
758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Koss-Olinger Consulting's 13F filing for Q4 2025, filed 10 Feb 2026.